Redeye Lunch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ Hansa Biopharma AB (NASDAQ Stockholm: HNSA) will publish its interim report for January-September 2022 at 8:00 CET on October 20, 2022. All.

United statesUnited kingdomVastra gotalands lanSan franciscoHansa biopharmaPrnewswire hansa biopharmaKlaus sindahlDonato spotaBryan garnierHealth careInterim reportRedeye after workRedeye lunchUgebrev life science conferenceRedeye life science dayErik penser banks temadag